These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Epigenetics: surveillance team against cancer. Klein G Nature; 2005 Mar; 434(7030):150. PubMed ID: 15758980 [No Abstract] [Full Text] [Related]
43. The oncogenic potential of deregulated homeobox genes. Maulbecker CC; Gruss P Cell Growth Differ; 1993 May; 4(5):431-41. PubMed ID: 8100147 [TBL] [Abstract][Full Text] [Related]
44. MicroRNAs in normal and cancer cells: a new class of gene expression regulators. Bagnyukova TV; Pogribny IP; Chekhun VF Exp Oncol; 2006 Dec; 28(4):263-9. PubMed ID: 17285108 [TBL] [Abstract][Full Text] [Related]
45. [Cancer--a disease of the genes]. Sauter G Praxis (Bern 1994); 1998 Apr; 87(16):535-7. PubMed ID: 9600016 [No Abstract] [Full Text] [Related]
47. Platelet-derived growth factor: roles in normal and v-sis transformed cells. Deuel TF; Kimura A; Maehama S; Tong BD Cancer Surv; 1985; 4(4):633-53. PubMed ID: 2824043 [TBL] [Abstract][Full Text] [Related]
48. Growth factors and oncogenes in human malignant glioma. Westermark B; Nister M; Heldin CH Neurol Clin; 1985 Nov; 3(4):785-99. PubMed ID: 3001490 [TBL] [Abstract][Full Text] [Related]
49. [The state of oncology at the end of the 20th century. Results--unknowns--perspectives]. García García G An R Acad Nac Med (Madr); 1993; 110(3):377-86. PubMed ID: 8116868 [No Abstract] [Full Text] [Related]
50. [Platelet-derived growth factor in normal and malignant cell growth]. Heldin CH; Westermark B; Wasteson A Nord Med; 1984; 99(12):319-22. PubMed ID: 6514566 [No Abstract] [Full Text] [Related]
51. The sis gene and PDGF. Williams LT Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086 [TBL] [Abstract][Full Text] [Related]
53. G protein-coupled receptor systems involved in cell growth and oncogenesis. Dhanasekaran N; Heasley LE; Johnson GL Endocr Rev; 1995 Jun; 16(3):259-70. PubMed ID: 7671848 [No Abstract] [Full Text] [Related]
54. [The role of oncogenes in carcinogenesis]. Ratajczak MZ; Urbanowska E Pol Tyg Lek; 1988 Nov; 43(47):1519-23. PubMed ID: 3075285 [No Abstract] [Full Text] [Related]
55. Neuro-oncogenesis. A review. Dănăilă L Rom J Neurol Psychiatry; 1992; 30(4):287-300. PubMed ID: 1299306 [No Abstract] [Full Text] [Related]
56. The gene as theme in the paradigm of cancer. Hall EJ Br J Radiol; 1993 Jan; 66(781):1-11. PubMed ID: 8428244 [No Abstract] [Full Text] [Related]
57. Oncogenes and tumor suppressor genes as paradigms in oncogenesis. Spandidos DA J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284 [TBL] [Abstract][Full Text] [Related]
58. [Cytologic molecular detection of oncogene expression: possibilities and prospects in hemato-oncology]. Greil R; Fasching B; Huber H Acta Med Austriaca; 1990; 17(1):6-10. PubMed ID: 2191534 [TBL] [Abstract][Full Text] [Related]
59. Inflammation and cancer: the oncogene-driven connection. Borrello MG; Degl'Innocenti D; Pierotti MA Cancer Lett; 2008 Aug; 267(2):262-70. PubMed ID: 18502035 [TBL] [Abstract][Full Text] [Related]
60. The etiology of human cancers. Kleihues P Prev Med; 1996; 25(1):13. PubMed ID: 8778752 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]